INFORMAZIONI SU QUESTO EPISODIO
Cell and gene therapies may well be some of the most important recent advancements in modern medicine. The way they work, however, is very complex and completely different from any pill that simply addresses symptoms. So, who are the pioneers in this field and what dares them to ask, “what if”? In this episode of the Biotech Innovators podcast, learn from Ainslie Little, senior vice president of corporate strategy at BlueRock Therapeutics, and how her company’s cell & gene platform is breaking new ground in this important space.
This content is offered for informational purposes only. The opinions stated in this podcast are that of the speaker and do not constitute or imply an endorsement by Thermo Fisher Scientific.
Inglese
Stati Uniti
TRASCRIZIONE 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
CERCA TRA GLI EPISODI PASSATI
Cerca gli episodi passati di Biotech Innovators: How it Started.
ALTRI EPISODI IN QUESTO PODCAST
Dr. Schiffman is a pediatric hematologist-oncologist and co-founder/CEO of PEEL Therapeutics headquartered in Salt Lake City, UT, USA and Haifa, Israel. It's a clinical-stage biotech company with a serendipitous origin story and a bright future. The company's name is the Hebrew word for e…
One of the greatest unexplored spaces in the world, is the microbiome: a bustling network of trillions of microorganisms living inside each of us. If we could learn more about them, the advances we’d make in healthcare and other fields would be incredible. This line of thinking is what spurred Tho…
Ever wonder how a small business can pivot when a global pandemic occurs? Josh Arant, co-founder MAKO Medical, discusses how they disrupted the status quo with passion and a heartfelt desire to give more to their clients. Then, how they rose to meet the needs of their community and country during a…
We're living during a time of enormous technological breakthroughs and innovation is the key to shaping the world.
However, when it comes to the biotech industry and biotechnological drug development, science has to always be at the center of them.
In this episode of the Biotech Innovators p…
Dichiarazione di non responsabilità: Il podcast e la grafica incorporati in questa pagina provengono da Thermo Fisher Scientific, che è di proprietà del suo proprietario e non è affiliato o approvato da Listen Notes, Inc.
MODIFICA
Grazie, ci hai aiutato a mantenere aggiornato il database dei podcast.
